Abbott Laboratories (ABT) Business Metric Overview - Stocknear

Abbott Laboratories

NYSE: ABT · Real-Time Price · USD
132.79
0.61 (0.46%)
At close: Sep 04, 2025, 3:54 PM

Abbott Laboratories Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Sep 30, 2011
Diagnostic Products Revenue 5.9B 2.05B 2.52B 2.41B 2.19B 2.21B 2.77B 2.45B 2.08B 2.69B 3.08B 3.9B 4.32B 5.29B 4.47B 3.91B 3.25B 4.01B 4.34B 2.64B 1.99B 1.83B 2.06B 1.91B 1.91B 1.84B 1.96B 1.82B 1.87B 1.84B 1.91B 1.28B 1.27B 1.16B 1.26B 1.21B 1.23B 1.12B 1.22B 1.16B 1.18B 1.09B 1.24B 1.18B 1.19B 1.12B 1.2B 1.13B 1.14B 1.09B 1.13B 1.04B 1.08B 1.04B 1.02B
Diagnostic Products Revenue Growth +187.24% -18.49% +4.48% +9.89% -0.86% -20.22% +13.31% +17.97% -22.77% -12.61% -21.13% -9.76% -18.24% +18.23% +14.29% +20.48% -19.11% -7.62% +64.58% +32.40% +9.20% -11.27% +7.81% +0.21% +3.48% -6.12% +7.51% -2.62% +1.96% -3.62% +49.02% +0.47% +9.93% -7.80% +3.54% -1.06% +9.66% -8.36% +5.54% -1.78% +7.69% -11.50% +4.66% -0.76% +6.45% -6.68% +6.40% -0.88% +4.32% -3.72% +8.45% -3.34% +3.45% +1.66% n/a
Established Pharmaceutical Products Revenue 1.38B 4.89B 1.27B 1.41B 1.29B 1.23B 1.22B 1.37B 1.29B 1.19B 1.22B 1.33B 1.22B 1.15B 1.2B 1.26B 1.18B 1.07B 1.15B 1.1B 1.01B 1.04B 1.17B 1.21B 1.11B 992M 1.09B 1.16B 1.13B 1.04B 1.15B 1.17B 1.02B 950M 979M 1.01B 980M 888M 885M 961M 977M 897M -20M 771M 1.22B 1.15B 1.29B 1.24B 1.22B 1.23B -11.52B 5.69B 5.63B 5.33B 1.39B
Established Pharmaceutical Products Revenue Growth -71.75% +286.04% -9.82% +8.66% +5.55% +0.33% -10.67% +6.29% +8.24% -2.22% -8.30% +8.42% +6.63% -4.66% -4.90% +7.20% +10.28% -6.71% +4.37% +8.49% -2.97% -11.07% -3.14% +9.39% +11.69% -8.99% -5.95% +2.66% +8.14% -8.82% -2.22% +14.69% +7.47% -2.96% -3.26% +3.27% +10.36% +0.34% -7.91% -1.64% +8.92% -4585.00% -102.59% -36.60% +5.65% -10.64% +4.29% +1.40% -1.22% -110.70% -302.53% +1.14% +5.57% +283.66% n/a
Medical Devices Revenue 5.37B 2.15B 5.05B 4.75B 4.73B 4.45B 4.44B 4.25B 4.29B 3.9B 3.75B 3.62B 3.76B 3.56B 3.75B 3.63B 3.67B 3.32B 3.26B 3.17B 2.42B 2.94B 3.2B 1.87B 1.88B 1.79B 1.78B 1.84B 1.86B 1.76B 1.78B 1.77B 1.73B 1.64B 1.73B 1.75B 1.74B 1.67B 1.8B 1.79B 1.72B 1.67B 1.8B 1.79B 1.73B 1.63B 1.7B 1.64B 1.7B 1.7B 1.72B 1.6B 1.58B 1.57B 1.54B
Medical Devices Revenue Growth +150.19% -57.52% +6.43% +0.27% +6.31% +0.23% +4.57% -1.07% +10.13% +4.00% +3.73% -3.78% +5.39% -4.91% +3.22% -0.93% +10.42% +1.93% +2.74% +30.83% -17.50% -8.33% +70.97% -0.05% +4.63% +0.84% -3.32% -1.08% +5.81% -1.57% +0.90% +2.14% +5.42% -5.25% -1.25% +0.86% +4.13% -7.17% +0.61% +4.19% +2.88% -7.48% +0.95% +3.24% +6.13% -4.17% +4.10% -4.05% +0.29% -0.99% +6.92% +1.33% +1.15% +1.89% n/a
Nutritional Products Revenue 2.21B 1.26B 2.13B 2.07B 2.15B 2.07B 2.04B 2.07B 2.08B 1.97B 1.82B 1.79B 1.95B 1.89B 2.04B 2.11B 2.11B 2.04B 1.94B 1.92B 1.88B 1.9B 1.87B 3.06B 3.08B 2.9B 2.39B 2.3B 2.42B 2.32B 2.32B 2.22B 2.26B 2.1B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Nutritional Products Revenue Growth +75.56% -40.82% +3.05% -3.91% +3.97% +1.47% -1.69% -0.14% +5.54% +8.26% +1.23% -8.09% +3.12% -7.25% -3.13% 0.00% +3.54% +5.17% +0.62% +2.18% -1.10% +1.93% -39.05% -0.33% +6.22% +21.13% +3.78% -4.87% +4.22% -0.04% +4.50% -1.59% +7.47% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
United States Revenue 4.28B 4.17B 6.63B 4.2B 3.93B 3.85B 6.29B 3.82B 3.76B 3.93B 5.87B 4.09B 4.89B 6.96B 6.61B 4.37B 6.64B 6.62B 6.5B 5.52B 4.69B 4.87B 5.35B 5.24B 5.13B 4.78B 7.97B 4.95B 5.07B 4.71B
United States Revenue Growth +2.59% -37.16% +57.85% +6.81% +2.29% -38.87% +64.84% +1.57% -4.33% -33.11% +43.43% -16.31% -29.69% +5.22% +51.40% -34.24% +0.36% +1.78% +17.70% +17.78% -3.70% -9.04% +2.14% +2.20% +7.28% -40.01% +61.04% -2.29% +7.42% n/a
Non-Us Revenue 6.87B 6.19B 4.34B 6.43B 6.44B 6.12B 3.95B 6.33B 6.22B 5.82B 4.22B 6.32B 6.37B 4.94B 4.86B 6.56B 3.58B 3.84B 4.2B 3.33B 2.64B 2.86B 2.96B 2.83B 2.85B 2.75B 2.75B 2.71B 2.7B 2.67B
Non-Us Revenue Growth +10.92% +42.59% -32.52% -0.16% +5.31% +54.93% -37.58% +1.70% +6.89% +37.92% -33.20% -0.77% +28.92% +1.69% -25.99% +83.19% -6.70% -8.60% +26.13% +26.19% -7.63% -3.51% +4.45% -0.56% +3.49% -0.04% +1.77% +0.19% +1.01% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 3.09B 3.05B 2.88B 2.9B 2.92B 2.95B 2.7B 2.69B 2.72B 2.75B 2.84B 2.73B 2.76B 2.79B 3B 2.77B 2.72B 2.78B 2.58B 2.3B 2.27B 2.55B 2.4B 2.41B 2.43B 2.46B 2.35B 2.36B 2.46B 2.53B 2.43B 2.08B 2.15B 2.3B 1.6B 1.62B 1.74B 1.7B 1.66B 1.67B 1.73B 1.74B
Selling, General, and Administrative Revenue Growth +1.31% +6.01% -0.52% -0.92% -1.08% +9.25% +0.33% -1.06% -0.98% -3.10% +4.15% -1.12% -1.08% -7.22% +8.60% +1.58% -2.16% +8.08% +12.15% +0.92% -10.71% +6.03% -0.46% -0.78% -1.14% +4.90% -0.64% -3.91% -2.77% +4.08% +16.73% -3.26% -6.48% +43.33% -0.87% -6.85% +2.30% +2.60% -0.66% -3.53% -0.58% n/a
Research and Development Revenue 732M 703M 728M 713M 697M 683M 690M 661M 710M 654M 691M 780M 684M 697M 758M 672M 654M 654M 698M 580M 564M 576M 575M 594M 577M 670M 561M 573M 573M 581M 618M 493M 520M 541M 338M 336M 348M 379M 369M 378M 345M 313M
Research and Development Revenue Growth +4.13% -3.43% +2.10% +2.30% +2.05% -1.01% +4.39% -6.90% +8.56% -5.35% -11.41% +14.04% -1.87% -8.05% +12.80% +2.75% 0.00% -6.30% +20.34% +2.84% -2.08% +0.17% -3.20% +2.95% -13.88% +19.43% -2.09% 0.00% -1.38% -5.99% +25.35% -5.19% -3.88% +60.06% +0.60% -3.45% -8.18% +2.71% -2.38% +9.57% +10.22% n/a